Bone morphogenetic proteins may benefit rates of union for open tibial fractures .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2016;4(3):18 PLoS One. 2015 Oct 28;10(10):e0141670.8 RCTs (1113 patients) comparing the use of bone morphogenetic proteins (BMPs) to conventional treatment methods for acute tibial fractures or tibial non-unions were included in this meta-analysis. The purpose of the study was to determine if BMPs improved the rate of union or decreased surgical revision rate compared to various standard practices. BMPs were found to significantly increase union rates and decrease revision rates when used for the treatment of acute tibial fractures but provided no additional benefit to treatment of tibial non-unions. The use of BMPs had no significant influence on the rate of infection for either type of injury when compared to standard care practices. It should be noted that majority of studies included in the acute fracture analyses only evaluated BMPs in open fractures and that both analyses for acute and non-union fractures were limited by the number of available randomized controlled trials.
Were the search methods used to find evidence (original research) on the primary question or questions stated?
Was the search for evidence reasonably comprehensive?
Were the criteria used for deciding which studies to include in the overview reported?
Was the bias in the selection of studies avoided?
Were the criteria used for assessing the validity of the included studies reported?
Was the validity of all of the studies referred to in the text assessed with use of appropriate criteria (either in selecting the studies for inclusion or in analyzing the studies that were cited)?
Were the methods used to combine the findings of the relevant studies (to reach a conclusion) reported?
Were the findings of the relevant studies combined appropriately relative to the primary question that the overview addresses?
Were the conclusions made by the author or authors supported by the data and or analysis reported in the overview?
How would you rate the scientific quality of this evidence?
Ja = 1
Ungewiss = 0.5
Nicht relevant = 0
Nein = 0
Die Bewertung der Berichtskriterien bewertet die Transparenz, mit der die Autoren die methodischen und studienspezifischen Merkmale der Studie in der Veröffentlichung angeben. Die Bewertung ist in fünf Kategorien unterteilt, die im Folgenden vorgestellt werden.
4/4
Introduction
3/4
Accessing Data
3/4
Analysing Data
4/4
Results
1/4
Discussion
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
Der Fragilitätsindex ist ein Instrument, das bei der Interpretation signifikanter Ergebnisse hilft und ein Maß für die Stärke eines Ergebnisses liefert. Der Fragilitätsindex gibt die Anzahl der aufeinanderfolgenden Ereignisse an, die zu einem dichotomen Ergebnis hinzugefügt werden müssen, damit das Ergebnis nicht mehr signifikant ist. Eine kleine Zahl steht für ein schwächeres Ergebnis und eine große Zahl für ein stärkeres Ergebnis.
Warum wurde diese Studie jetzt benötigt?
Tibial fractures most commonly result from high-energy trauma and are associated with high rates of delayed union and nonunion. Conventional treatment methods, including intramedullary nailing or locking plate fixation, have previously been combined with biological substances, such as bone morphogenetic proteins (BMPs), in order to accelerate healing and decrease disability. BMPs play a role in bone formation/repair and have been found to hasten bone union and decrease revision rates in previous studies. While prior meta-analyses evaluating the efficacy of BMPs for tibial fracture healing have been conducted, they were limited by the quality and quantity of existing studies. The current meta-analysis was needed to combine large, high-quality randomized trials to overcome the limitations of previous reviews.
Was war die wichtigste Forschungsfrage?
Does the use of bone morphogenetic protein (BMP) in the treatment of tibial fractures improve the rate of union/revision when compared to the use of standard care in both acute and non-union fractures?
- 4 RCTs (868 patients) involved patients with acute tibial fractures (3 studies included open fractures/ 1 study included both open and closed fractures). 4 RCTs (245 patients) involved patients with tibial fracture non-union.
- In acute tibial fracture patients, rate of bone union was significantly higher in the BMP group (65%) compared to standard care alone (58.8%) (4 studies [868 patients], RR=1.16 [95% CI 1.04 to 1.30]; I2=14%).
- In acute tibial fracture patients, rate of revision surgery was significantly lower in the BMP group (23%) compared to standard care alone (29.4%) (5 studies [853 patients], RR=0.68 [95% CI 0.54 to 0.85]; I2= 5%).
- In acute tibial fracture patients, rate of hardware failure was not significantly different (4 studies [744 patients], RR=0.77 [95% CI 0.50 to 1.18]; I2=32%), and there were no differences in infection rate between groups (4 studies [744 patients], RR= 1.07 [95% CI 0.66 to 1.74]; I2=54%).
- In tibial non-union patients, rate of bone union was similar between treatment groups (4 studies [245 patients], RR=0.98 [95% CI 0.86 to 1.13]; I2=53%).
- In tibial non-union patients, rate of surgical revision was lower in the BMP group compared to standard care alone but the difference was not significant (1 study [124 patients], RR=0.48 [95% CI 0.13 to 1.85]; I2=NA).
- In tibial nonunion patients, infection rate was lower in the BMP group compared to standard care alone but not significantly different (2 studies [154 patients], RR= 0.61 [95% CI 0.37 to 1.02]; I2=0%).
Was sollte ich mir besonders merken?
When used to treat acute tibial fractures, bone morphogenetic proteins were found to significantly improve union rate and reduce surgical revision rate compared to standard practice alone. It should be noted that the majority of patient included in this analyses came from studies only investigating open fractures, so findings may not be representative of a closed fracture population. Results from analyses investigating treatment of tibial non-unions found no significant effects between groups. Additionally, bone morphogenetic proteins had no significant influence on infection rate for either type of injury.
Wie wird sich dies auf die Behandlung meiner Patienten auswirken?
The findings from this study suggest the use bone morphogenetic proteins (BMP) may be beneficial for the treatment of acute tibial fractures, improving union rate and reducing the need for surgical revision. However, these finding may only be applicable to open fractures. The use of bone morphogenetic proteins in the treatment of tibial non-unions suggests that they may not provide any additional benefit over standard care. While this study presents supportive evidence for the benefits of BMP in the treatment of tibial fractures, results should be interpreted with caution due to the low number of studies included and the assumed high heterogeneity as a result of the low statistical power. Therefore, additional high-quality studies utilizing larger sample sizes and longer follow-up times should be undertaken to further verify the efficacy of this treatment practice.
HAFTUNGSAUSSCHLUSS
Der Inhalt dieser Seite dient nur zu Informationszwecken und ist nicht als Ersatz für professionelle medizinische Beratung, Diagnose oder Behandlung gedacht. Wenn Sie eine medizinische Behandlung benötigen, wenden Sie sich immer an Ihren Arzt oder suchen Sie die nächstgelegene Notaufnahme auf. Die Meinungen, Überzeugungen und Standpunkte, die von den Personen auf dieser Seite geäußert werden, spiegeln nicht die Meinungen, Überzeugungen und Standpunkte von OrthoEvidence wider.
0 von 4 monatliche KOSTENLOSE Artikel freigeschaltet
